What the literature (and patient experience) says about Mounjaro and PCOS, NASH, kidneys, eyes, brain, gut, fertility, cholesterol, and inflammation.
"Herein we investigated the effects of the GLP-1 receptor agonist, Exendin-4 (Ex4), on various measures of alcohol-induced reward as well as on alcohol intake and alcohol seeking behavior in rodents.…
Read → The SURMOUNT-3 trial article, linked to elsewhere in this document, has excellent visual aids showing comparisons between 5mg, 10mg & 15mg on many health markers, including cholesterol lowering results. ![][image12]…
Read → Mounjaro is not a treatment for eating disorders. If you have been diagnosed with an eating disorder, discuss taking this medication with your medical providers. If you believe you have…
Read → HbA1c Change and Diabetic Retinopathy During GLP-1 Receptor Agonist Cardiovascular Outcome Trials: A Meta-analysis and Meta-regression Diabetes Care, January 2021 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7783944/
Read → Anti-Inflammatory Effects of GLP-1-Based Therapies beyond Glucose Control Mediators Inflamm, 2016 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4823510/ "The clinical effect observed and the direct interaction between GLP-1 and the immune system raise the possibility of…
Read → "Dual receptor agonism is both additive and complementary, Dr. Green explained. GLP-1 activity reduces food intake, improves insulin secretion, reduces glucagon secretion, and delays gastric emptying. GIP activity also reduces…
Read → "GLP-1 RAs may act directly on the hepatocytes. Transgenic rats deficient in dipeptidyl peptidase-4 (DPP4-), the enzyme that degrades endogenous GLP-1, have a threefold higher basal active GLP-1; they not…
Read → The SURMOUNT-3 trial article (linked elsewhere in this document!) has much information on weight loss t results and reduction in waist circumference, with great visual aids illustrating findings on this…
Read → There's research linking PCOS to Diabetes and also GLP-1RA therapies having a positive effect on those with PCOS. See more: https://www.healthline.com/health/diabetes/are-pcos-and-diabetes-connected Lamos EM, Malek R, Davis SN. GLP-1 receptor agonists…
Read → "Currently, there is no disease-modifying treatment available for Alzheimer's and Parkinson's disease (AD and PD) and that includes the highly controversial approval of the Aβ-targeting antibody aducanumab for the treatment…
Read → "Recently, studies in humans and preclinical models have found associations between alterations in the gut microbiome and the metabolic/clinical features of PCOS. It is theorized that gut dysbiosis could be…
Read → Because Mounjaro, as an incretin mimetic, changes metabolic hormone signaling in the body, which also creates a domino effect of other hormones in the body (including sex hormones), expect potential…
Read →